Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cormedix Inc. (CRMD)  
$5.12 0.08 (1.54%) as of 4:30 Fri 5/17


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 32,130,000
Market Cap: 164.51(M)
Last Volume: 33,837 Avg Vol: 33,744
52 Week Range: $2.94 - $6.39
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 5.8
Insider 6 Months    : 7.1
Insider 3/6 Months : 13.3
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Co.'s primary focus is on the development of its primary product candidate, DefenCath™, for potential commercialization in the U.S. and other main markets. Co. has in-licensed the worldwide rights to develop and commercialize DefenCath and Neutrolin®. DefenCath/Neutrolin is an anti-infective solution intended for the reduction of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis and total parenteral nutrition.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 13,561 19,561 30,561 89,261
Total Buy Value $50,718 $70,968 $112,068 $360,265
Total People Bought 1 2 3 6
Total Buy Transactions 1 3 5 12
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 213
  Page 6 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Tellez Cora M Director   •       •      –    2017-05-01 4 AB $0.66 $3,156 D/D 4,800 124,821     -
   Tellez Cora M Director   •       •      –    2017-03-30 4 AB $1.66 $3,237 D/D 1,950 120,021     -
   Tellez Cora M Director   •       •      –    2017-02-28 4 AB $2.10 $3,231 D/D 1,540 118,071     -
   Pfaffle Antony Chief Scientific Officer   •       •      –    2017-02-07 4 AS $2.00 $20,000 D/D (10,000) 0     -
   Pfaffle Antony Chief Scientific Officer   •       •      –    2017-02-07 4 OE $0.68 $6,800 D/D 10,000 10,000     -
   Tellez Cora M Director   •       •      –    2017-01-30 4 AB $1.79 $3,183 D/D 1,780 116,531     -
   Tellez Cora M Director   •       •      –    2016-12-30 4 AB $1.58 $3,144 D/D 1,990 114,751     -
   Baluch Khoso Chief Executive Officer   •       •      –    2016-12-09 4 B $1.77 $17,700 D/D 10,000 10,000 2.81     -
   Tellez Cora M Director   •       •      –    2016-11-30 4 AB $1.80 $3,240 D/D 1,800 112,761     -
   Tellez Cora M Director   –       •      –    2016-10-31 4 AB $2.15 $3,171 D/D 1,475 110,961     -
   Pfaffle Antony Chief Scientific Officer   •       •      –    2016-10-21 4 AS $2.23 $44,600 D/D (20,000) 0     -
   Pfaffle Antony Chief Scientific Officer   •       •      –    2016-10-21 4 OE $0.68 $13,600 D/D 20,000 20,000     -
   Markvicka Taunia Director   •       •      –    2016-08-25 4 B $1.65 $30,690 D/D 18,600 22,600 2.39     -
   Kaplan Myron Director   •       •      –    2016-08-19 4 B $1.72 $34,496 D/D 20,000 20,000 2.81     -
   Tellez Cora M Director   •       •      –    2016-08-19 4 B $1.73 $21,588 D/D 12,500 109,486 2.39     -
   Milby Randy Chief Executive Officer   •       •      –    2016-08-09 4 OE $0.29 $14,500 I/I 50,000 246,243     -
   Milby Randy Chief Executive Officer   •       •      –    2016-08-09 4 OE $0.68 $68,000 D/D 100,000 157,026     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-21 4 S $2.11 $41,772 D/D (19,657) 0     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-21 4 OE $0.68 $13,367 D/D 19,657 19,657     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-20 4 S $2.14 $21,569 D/D (10,000) 0     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-20 4 OE $0.68 $6,800 D/D 10,000 10,000     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-15 4 S $2.21 $10,818 D/D (4,900) 0     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-15 4 OE $0.68 $3,332 D/D 4,900 4,900     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-13 4 S $2.20 $975 D/D (443) 0     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-06-13 4 OE $0.68 $301 D/D 443 443     -
  213 Records found
  1  2  3  4  5  6  7  8  9   
  Page 6 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us